Biomedical Engineering Reference
In-Depth Information
103. Lahjouji K, Mitchell GA, Qureshi IA. 2001. Carnitine transport by organic cation trans-
porters and systemic carnitine deficiency. Mol Genet Metab 73:287-297.
104. Lamhonwah AM, Olpin SE, Pollitt RJ, Vianey-Saban C, Divry P, Guffon N, Besley GT,
Onizuka R, De Meirleir LJ, et al. 2002. Novel OCTN2 mutations: no genotype-phenotype
correlations: early carnitine therapy prevents cardiomyopathy. Am J Med Genet 111:271-
284.
105. Eraly SA, Hamilton BA, Nigam SK. 2003. Organic anion and cation transporters occur in
pairs of similar and similarly expressed genes. Biochem Biophys Res Commun 300:333-
342.
106. Wu X, Prasad PD, Leibach FH, Ganapathy V. 1998. cDNA sequence, transport func-
tion, and genomic organization of human OCTN2, a new member of the organic cation
transporter family. Biochem Biophys Res Commun 246:589-595.
107. Russell RK, Drummond H, Nimmo E, Anderson N, Noble C, Wilson D, Gillett P, McGro-
gan P, Hassan K, Weaver L, et al. 2006. Analysis of the influence of OCTN1/2 variants
within the IBD5 locus on disease susceptibility and growth parameters in early-onset
inflammatory bowel disease. Gut 55:1114-1123.
108. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M,
Ohtsuki M, Ono M, et al. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4,
encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet
35:341-348.
109. Grundemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A,
Schomig E. 2005. Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A
102:5256-5261.
110. Tokui T, Nakai D, Nakagomi R, Yawo H, Abe T, Sugiyama Y. 1999. Pravastatin, an HMG-
CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide,
oatp2. Pharm Res 16:904-908.
111. Mwinyi J, Johne A, Bauer S, Roots I, Gerloff T. 2004. Evidence for inverse effects of
OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics. Clin Pharmacol Ther
75:415-421.
112. Merezhinskaya N, Fishbein WN, Davis JI, Foellmer JW. 2000. Mutations in MCT1 cDNA
in patients with symptomatic deficiency in lactate transport. Muscle Nerve 23:90-97.
113. Coles L, Litt J, Hatta H, Bonen A. 2004. Exercise rapidly increases expression of the
monocarboxylate transporters MCT1 and MCT4 in rat muscle. J Physiol 561:253-261.
114. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan
K, Childs S, Ling V, et al. 1998. A gene encoding a liver-specific ABC transporter is
mutated in progressive familial intrahepatic cholestasis. Nat Genet 20:233-238.
115. Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, Koning
JH, De Jager-Krikken A, Kuipers F, Stellaard F, et al. 1999. Hepatocanalicular bile salt
export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Gastroenterology 117:1370-1379.
116. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, Bernard O,
Hadchouel M. 1996. Defect of multidrug-resistance 3 gene expression in a subtype of
progressive familial intrahepatic cholestasis. Hepatology 23:904-908.
117. Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D, Kubitz
R. 2005. Expression and localization of hepatobiliary transport proteins in progressive
familial intrahepatic cholestasis. Hepatology 41:1160-1172.
Search WWH ::
Custom Search